CLINICAL_TRIALS
trial_result
· 2017-01-11
Clinical Trial Update: A Study of the Safety and Efficacy of MK-3577 in Participants With Type 2 Diabetes Mellitus (MK-3577-009) [Phase 2]
Summary
Phase 2 study of MK-3577 in type 2 diabetes mellitus was terminated with posted results in 2017.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: TERMINATED | Results posted: 2017-01-11